14 June 2023
Antibodies Receives an Increased CiteScore of 9.6


We are pleased to inform you that Antibodies (ISSN: 2073-4468) has received an updated CiteScore of 9.6, an increase of 967% compared with the 2021 metric. The 2022 CiteScore™ was released recently, making an assessment of the scientific influence of journals in the 2019 to 2022 period.

Antibodies’ CiteScore ranks as follows:

  • Q1 (23 out of 156) in the "Drug Discovery" category;
  • Q1 (46 out of 211) in the "Immunology and Allergy" category;
  • Q1 (49 out of 217) in the "Immunology" category.

For more journal statistics, please visit https://www.mdpi.com/journal/antibodies/stats.

Excellent performance is inseparable from the support and dedication of all journal editors, reviewers, authors, and readers. We would like to take this opportunity to thank all of you who have contributed to the journal.

Back to TopTop